Please wait

Exhibit 107.1

Calculation of Filing Fee

Form S-8

(Form Type)

Enliven Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

               

Security

Type

 

Security

Class

Title

 

Fee

 Calculation 

Rule

 

Amount

Registered (1)

 

Proposed

 Maximum 

Offering

Price

Per Unit

 

 Maximum 

 Aggregate 

Offering Price

 

Fee

Rate

 

Amount of

Registration 

Fee

               
Equity  

Common Stock,

par value

$0.001

per share,

reserved for

issuance

pursuant to the

Registrant’s

Amended and

Restated 2020

Equity

Incentive Plan

(the “2020

Plan”)

  Other   2,900,000 (2)   $21.71 (3)   $62,959,000.00    0.00014760   $9,292.75
         
Total Offering Amounts     $62,959,000.00      $9,292.75
         
Total Fee Offsets        
         
Net Fee Due               $9,292.75
(1)

Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-8 (the “Registration Statement”) shall also cover any additional shares of the Registrant’s common stock, par value $0.001 per share (the “Common Stock”) that become issuable with respect to the securities identified in the above table under the 2020 Plan by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the registrant’s receipt of consideration which results in an increase in the number of outstanding shares of Common Stock.

(2)

Represents an increase of 2,900,000 shares of Common Stock reserved for issuance under the 2020 Plan for issuance upon the exercise or settlement of awards that may be granted under the 2020 Plan, which increase was approved by the Registrant’s stockholders through an amendment and restatement of the 2020 Plan on June 18, 2024.

(3)

Estimated in accordance with Rule 457(c) and Rule 457(h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $21.71 per share, which is the average of the high and low prices of Common Stock, as reported on The Nasdaq Global Select Market, on June 17, 2024, which date is within five business days prior to the filing of this Registration Statement.